Copyright
©The Author(s) 2024.
World J Stem Cells. Mar 26, 2024; 16(3): 257-266
Published online Mar 26, 2024. doi: 10.4252/wjsc.v16.i3.257
Published online Mar 26, 2024. doi: 10.4252/wjsc.v16.i3.257
Table 2 Fistula closure and recurrence, n (%)
| Total | Anti-TNF (n = 27) | Without anti-TNF (n = 38) | P value | |
| Cumulative closure rate | 50/65 (76.9%) | 18/27 (66.7%) | 32/38 (84.2%) | 0.098 |
| 1-yr | 43 (66.2) | 17 (63.0) | 26 (68.4) | |
| 2-yr | 48 (73.8) | 18 (66.7) | 30 (78.9) | |
| 3-yr | 49 (75.4) | - | 31 (81.6) | |
| Closure time (months) | 6.94 ± 9.68 | 4.56 ± 4.37 | 8.28 ± 11.52 | 0.195 |
| Cumulative recurrence rate | 7/50 (14.0) | 3/18 (16.7) | 4/32 (12.5) | 0.684 |
| 1-yr | 4 (8.0) | 2 (11.1) | 2 (6.3) | |
| 2-yr | 5 (10.0) | 3 (16.7) | 2 (6.3) | |
| 3-yr | 7 (14.0) | - | 4 (12.5) | |
| Recurrence time (months) | 16.57 ± 19.38 | 7.33 ± 7.77 | 23.50 ± 23.70 | 0.316 |
- Citation: Park MY, Yoon YS, Park JH, Lee JL, Yu CS. Long-term outcome of stem cell transplantation with and without anti-tumor necrotic factor therapy in perianal fistula with Crohn’s disease. World J Stem Cells 2024; 16(3): 257-266
- URL: https://www.wjgnet.com/1948-0210/full/v16/i3/257.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i3.257